Five-year outcomes following complex reconstructive surgery for infective endocarditis involving the intervalvular fibrous body
Why the study?
What are the five-year survival and freedom from reoperation rates following double valve replacement with reconstruction of the IFB in patients with complex infective endocarditis?
Population
Patients with complex IE
Comparison
Double valve replacement with reconstruction of the IFB
Follow-up
Five-year
Authors
Discussion
Loading...
Member takes
Implication
High early risk warrants cautious patient selection in complex IE; leaves open need for prospective data on reconstruction durability.
Key Points
- To evaluate five-year clinical outcomes, survival rates, and freedom from reoperation following complex double-valve replacement with reconstruction of the intervalvular fibrous body for infective endocarditis.
- Followed patients undergoing double valve replacement and intervalvular fibrous body reconstruction for complex infective endocarditis.
- Assessed short-term morbidity and mortality within 90 days of surgery alongside intermediate five-year survival and reoperation rates.
- Complex reconstructive surgery for infective endocarditis entails high early morbidity and elevated mortality, particularly within the first 90 postoperative days.
- Patients surviving past the initial 90-day window achieve acceptable survival and freedom from reoperation up to five years post-surgery.
Structured PICO
What are the five-year survival and freedom from reoperation rates following double valve replacement with reconstruction of the IFB in patients with complex infective endocarditis?
P
Population
Patients with complex infective endocarditis (IE) involving the intervalvular fibrous body (IFB)
I
Intervention
Double valve replacement with reconstruction of the intervalvular fibrous body (IFB)
O
Outcome
Survival, freedom from reoperation, morbidity, and mortality at 5 yearshard clinical
Complex reconstructive surgery for infective endocarditis involving the intervalvular fibrous body carries high early risk but offers acceptable long-term survival and freedom from reoperation.
Cite This Study
Davierwala et al. (2020) studied this question.